Company profile FIXX
After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 0 |
| 2019 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 399 inf% YoY inf% QoQ | 256 inf% YoY -35.8% QoQ |
| 2021 | 335 inf% YoY 30.9% QoQ | 197 inf% YoY -41.2% QoQ | 183 -54.1% YoY -7.1% QoQ | 301 17.6% YoY 64.5% QoQ |
| 2022 | 454 35.5% YoY 50.8% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
The average 5 years interest of Homology Medicines -stock was 8.17 per week. The last year interest of Homology Medicines -stock compared to the last 5 years has changed by -100.0%. This is something to be checked. This didn't exist 5 years ago.
There is not enough data for Homology Medicines login to provide analysis
There is not enough data for Homology Medicines login to provide correlation calculation
There is not enough data for Homology Medicines login to provide analysis
There is not enough data for Homology Medicines gene therapy to provide analysis
There is not enough data for Homology Medicines gene therapy to provide correlation calculation
There is not enough data for Homology Medicines gene therapy to provide analysis
There is not enough data for adeno-associated virus vectors to provide analysis
There is not enough data for adeno-associated virus vectors to provide correlation calculation
There is not enough data for adeno-associated virus vectors to provide analysis
There is not enough data for genetic medicines company to provide analysis
There is not enough data for genetic medicines company to provide correlation calculation
There is not enough data for genetic medicines company to provide analysis
There is not enough data for nuclease-free gene editing to provide analysis
There is not enough data for nuclease-free gene editing to provide correlation calculation
There is not enough data for nuclease-free gene editing to provide analysis
There is not enough data for HMI-102 clinical trial to provide analysis
There is not enough data for HMI-102 clinical trial to provide correlation calculation
There is not enough data for HMI-102 clinical trial to provide analysis
There is not enough data for phenylketonuria (PKU) treatment to provide analysis
There is not enough data for phenylketonuria (PKU) treatment to provide correlation calculation
There is not enough data for phenylketonuria (PKU) treatment to provide analysis
There is not enough data for metachromatic leukodystrophy treatment to provide analysis
There is not enough data for metachromatic leukodystrophy treatment to provide correlation calculation
There is not enough data for metachromatic leukodystrophy treatment to provide analysis
There is not enough data for mucopolysaccharidosis type II treatment to provide analysis
There is not enough data for mucopolysaccharidosis type II treatment to provide correlation calculation
There is not enough data for mucopolysaccharidosis type II treatment to provide analysis
There is not enough data for paroxysmal nocturnal hemoglobinuria treatment to provide analysis
There is not enough data for paroxysmal nocturnal hemoglobinuria treatment to provide correlation calculation
There is not enough data for paroxysmal nocturnal hemoglobinuria treatment to provide analysis
After 34 days of this quarter the interest is at 166.0. Based on that we can calculate that during remaining 58 days it will total up to 449.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 237 |
| 2019 | 515 117.3% QoQ | 316 -38.6% QoQ | 174 -44.9% QoQ | 302 27.4% YoY 73.6% QoQ |
| 2020 | 235 -54.4% YoY -22.2% QoQ | 266 -15.8% YoY 13.2% QoQ | 116 -33.3% YoY -56.4% QoQ | 146 -51.7% YoY 25.9% QoQ |
| 2021 | 258 9.8% YoY 76.7% QoQ | 332 24.8% YoY 28.7% QoQ | 273 135.3% YoY -17.8% QoQ | 234 60.3% YoY -14.3% QoQ |
| 2022 | 419 62.4% YoY 79.1% QoQ | 388 16.9% YoY -7.4% QoQ | 240 -12.1% YoY -38.1% QoQ | 330 41.0% YoY 37.5% QoQ |
| 2023 | 361 -13.8% YoY 9.4% QoQ | 319 -17.8% YoY -11.6% QoQ | 369 53.8% YoY 15.7% QoQ | 166 -49.7% YoY -55.0% QoQ |
The average 5 years interest of rare genetic diseases was 22.97 per week. The last year interest of rare genetic diseases compared to the last 5 years has changed by 14.71%. The interest for rare genetic diseases is seasonal. The last year interest is comparable to 5 years ago. It has changed only by -1.01%.